Correction: quantitative analysis of ligand-EGFR interactions: a platform for screening targeting molecules.

Correction: quantitative analysis of ligand-EGFR interactions: a platform for screening targeting molecules.

[This corrects the article DOI: 10.1371/journal.pone.0116610.].

Bibliographic Details
Main Authors:	Wei-Ting Kuo, Wen-Chun Lin, Kai-Chun Chang, Jian-Yuan Huang, Ko-Chung Yen, In-Chi Young, Yu-Jun Sun, Feng-Huei Lin
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2015-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4395251?pdf=render

Similar Items

Quantitative analysis of ligand-EGFR interactions: a platform for screening targeting molecules.
by: Wei-Ting Kuo, et al.
Published: (2015-01-01)

Correction: Magnetic Nanoparticles as Mediators of Ligand-Free Activation of EGFR Signaling.
by: Atul A. Bharde, et al.
Published: (2013-01-01)

Correction: Magnetic Nanoparticles as Mediators of Ligand-Free Activation of EGFR Signaling
Published: (2013-01-01)

A Rapid and Quantitative Fluorimetric Method for Protein-Targeting Small Molecule Drug Screening
by: Yu, Yong, et al.
Published: (2015)

Improved survival in patients with unresectable stage III EGFR‐mutant adenocarcinoma with upfront EGFR‐tyrosine kinase inhibitors
by: Sheng‐Yuan Wang, et al.
Published: (2022-01-01)

Identification of a small-molecule ligand of the epigenetic reader protein Spindlin1 via a versatile screening platform
by: Wagner, T, et al.
Published: (2016)

Single-Molecule Super-Resolution Microscopy Reveals Heteromeric Complexes of MET and EGFR upon Ligand Activation
by: Marie-Lena I.E. Harwardt, et al.
Published: (2020-04-01)

Outcomes of salvage lung resections in advanced EGFR‐mutant lung adenocarcinomas under EGFR TKIs
by: Ying‐Yuan Chen, et al.
Published: (2021-10-01)

Chemotherapy outcomes in EGFR‐TKI resistant patients with common and uncommon EGFR mutation: An exploratory retrospective cohort study
by: Chien‐Yu Lin, et al.
Published: (2023-07-01)

Ligand-induced transmembrane conformational coupling in monomeric EGFR
by: Shwetha Srinivasan, et al.
Published: (2022-07-01)

Author Correction: Anti-inflammatory effect of afatinib (an EGFR-TKI) on OGD-induced neuroinflammation
by: Yen-Ju Chen, et al.
Published: (2021-01-01)

Confinement of unliganded EGFR by tetraspanin nanodomains gates EGFR ligand binding and signaling
by: Michael G. Sugiyama, et al.
Published: (2023-05-01)

The Co-Expression of Programmed Death-Ligand 1 (PD-L1) in Untreated EGFR-Mutated Metastatic Lung Adenocarcinoma
by: Ping-Chih Hsu, et al.
Published: (2020-02-01)

Correction: GroEL1, from , Induces Vascular Adhesion Molecule 1 Expression by p37 in Endothelial Cells and Hypercholesterolemic Rabbit.
by: Chun-Yao Huang, et al.
Published: (2012-01-01)

Phenotypic screening and fragment-based approaches to the discovery of small-molecule bromodomain ligands.
by: Jennings, L, et al.
Published: (2014)

Toward High-throughput, Quantitative Platforms to Identify the Targets of Small Molecules
by: Henry, Catherine Campbell
Published: (2023)

Identifying potential ligand molecules EGFR mediated TNBC targeting the kinase domain-identification of customized drugs through in silico methods
by: Hima Vyshnavi, et al.
Published: (2023-01-01)

Efficacy of Definitive Radiotherapy for Patients with Clinical Stage IIIB or IIIC Lung Adenocarcinoma and Epidermal Growth Factor Receptor (EGFR) Mutations Treated Using First- or Second-Generation EGFR Tyrosine Kinase Inhibitors
by: Chih-Yen Tu, et al.
Published: (2024-01-01)

Quantification of ligand and mutation-induced bias in EGFR phosphorylation in direct response to ligand binding
by: Daniel Wirth, et al.
Published: (2023-11-01)

Using quantitative single molecule localization microscopy to optimize multivalent HER2-targeting ligands
by: Devin L. Wakefield, et al.
Published: (2023-04-01)

Brain metastasis, EGFR mutation subtype and generation of EGFR-TKI jointly influence the treatment outcome of patient with EGFR-mutant NSCLC
by: Jia-Shiuan Ju, et al.
Published: (2023-11-01)

Identification of orphan ligand-receptor relationships using a cell-based CRISPRa enrichment screening platform
by: Dirk H Siepe, et al.
Published: (2022-09-01)

Recombinant Baculovirus: A Flexible Drug Screening Platform for Chikungunya Virus
by: Muhammed Muhsin Varikkodan, et al.
Published: (2021-07-01)

Effect of EGFR on SQSTM1 Expression in Malignancy and Tumor Progression of Oral Squamous Cell Carcinoma
by: Yu-Kai Tseng, et al.
Published: (2021-11-01)

The EGFR ligands Spitz and Keren act cooperatively in the Drosophila eye.
by: Brown, K, et al.
Published: (2007)

Microglial-stimulation of glioma invasion involves the EGFR ligand amphiregulin.
by: Salvatore J Coniglio, et al.
Published: (2021-01-01)

Magnetic nanoparticles as mediators of ligand-free activation of EGFR signaling.
by: Atul A Bharde, et al.
Published: (2013-01-01)

Irregular Antibody Screening Using a Microdroplet Platform
by: Ding-Ping Chen, et al.
Published: (2023-09-01)

SPR-based fragment screening with neurotensin receptor 1 generates novel small molecule ligands.
by: Sylwia Huber, et al.
Published: (2017-01-01)

1130 Design and characterization of novel TLR7-selective ligands with an automated screening platform
by: Siri Tähtinen, et al.
Published: (2023-11-01)

Computer-assisted three-dimensional quantitation of programmed death-ligand 1 in non-small cell lung cancer using tissue clearing technology
by: Yen-Yu Lin, et al.
Published: (2022-03-01)

Screening transferable microsatellite markers across genus Phalaenopsis (Orchidaceae)
by: Ya-Zhu Ko, et al.
Published: (2017-11-01)

A kinetically controlled platform for ligand-oligonucleotide transduction
by: Qiu-Long Zhang, et al.
Published: (2021-08-01)

Assessing EGFR‐mutated NSCLC with bone metastasis: Clinical features and optimal treatment strategy
by: Wei‐Chun Chen, et al.
Published: (2024-04-01)

The surgical resection of the primary tumor increases survival in patients with EGFR-mutant advanced non-small cell lung cancer: a tertiary center cohort study
by: Ying-Yuan Chen, et al.
Published: (2022-12-01)

Preventing and treating brain metastases with three first-line EGFR-tyrosine kinase inhibitors in patients with EGFR mutation-positive advanced non-small cell lung cancer
by: Po-Lan Su, et al.
Published: (2018-09-01)

Ligand hydration and bridging waters molecules
by: Sridhar, A
Published: (2016)

Blimp-1 Upregulation by Multiple Ligands via EGFR Transactivation Inhibits Cell Migration in Keratinocytes and Squamous Cell Carcinoma
by: Hyemin Lee, et al.
Published: (2022-02-01)

Ectodomain shedding of EGFR ligands serves as an activation readout for TRP channels.
by: Manae Tatsumi, et al.
Published: (2023-01-01)

Distinct effects of EGFR ligands on human mammary epithelial cell differentiation.
by: Chandrani Mukhopadhyay, et al.
Published: (2013-01-01)